The Latin America, Middle East and Africa Cardiac Marker Testing Market would witness market growth of 10.6% CAGR during the forecast period (2022-2028).
Patients with chest pain and suspicion of acute coronary syndrome are diagnosed and risk-stratified using cardiac markers, and cardiac troponin (especially troponin I) is particularly helpful in the diagnosis of myocardial infection because of its higher specificity compared to certain other cardiac markers. Non-ST-segment elevation MI is now the term used to describe people with myocardial infarction symptoms and high troponin I or troponin T but no alterations in their electrocardiogram.
There are now high-sensitivity cardiac troponin assays that can measure troponin readings at significantly lower concentrations. More individuals with unstable angina will be labeled as having non-ST-elevation myocardial infarction due to the use of these high-sensitivity diagnostics. These tests may therefore identify a group of individuals who are at high risk, which could then receive more suitable treatment and have better results.
One aspect of the increase in illnesses is the region's population's aging. The country of South Africa has an estimated population of 56.5 million people, according to Statistics South Africa's most recent mid-year population predictions. Furthermore, South Africa's elderly population—defined as those 60 and older—is increasing and reached 8.1% in 2017. In South Africa, there are 4.6 million people over the age of 60.
The Brazil market dominated the LAMEA Cardiac Marker Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $127.1 million by 2028.The Argentina market is experiencing a CAGR of 11.2% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 10.3% during (2022 - 2028).
Based on Disease, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Atherosclerosis, Acute Coronary Syndrome and Ischemia. Based on End User, the market is segmented into Laboratory Testing Facilities, Point-of-Care Testing Facilities and Academic Institutions. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Biomarker Type, the market is segmented into Troponin I & T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP) and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Cardiac Marker Testing Market is Predict to reach $8.1 Billion by 2028, at a CAGR of 8.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.
Scope of the Study
Market Segments Covered in the Report:
By Disease
- Myocardial Infarction
- Congestive Heart Failure
- Atherosclerosis
- Acute Coronary Syndrome
- Ischemia
By End User
- Laboratory Testing Facilities
- Point-of-Care Testing Facilities
- Academic Institutions
By Product
- Reagents & Kits
- Instruments
By Biomarker Type
- Troponin I & T
- Creatine kinase-MB(CK-MB)
- Natriuretic peptide (Bnp Or Nt-Probnp)
- Myoglobin
- High-sensitivity C-reactive protein(hs-CRP)
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers AG (Siemens AG)
- PerkinElmer, Inc.
- BioMérieux S.A.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- DiaSorin S.p.A.
TABLE 1 LAMEA Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cardiac Marker Testing Market
TABLE 4 Product Launches And Product Expansions– Cardiac Marker Testing Market
TABLE 5 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 6 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 7 LAMEA Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 8 LAMEA Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 9 LAMEA Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 LAMEA Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 LAMEA Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 28 LAMEA Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 29 LAMEA Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 34 LAMEA Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 35 LAMEA Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 47 LAMEA Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 48 LAMEA Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 49 Brazil Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 50 Brazil Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 51 Brazil Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 52 Brazil Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 53 Brazil Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 Brazil Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 Brazil Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 56 Brazil Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 57 Brazil Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 58 Brazil Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 59 Argentina Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 60 Argentina Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 61 Argentina Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 62 Argentina Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 63 Argentina Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 64 Argentina Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 65 Argentina Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 66 Argentina Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 67 Argentina Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 68 Argentina Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 69 UAE Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 70 UAE Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 71 UAE Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 72 UAE Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 73 UAE Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 74 UAE Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 75 UAE Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 76 UAE Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 77 UAE Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 78 UAE Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 79 Saudi Arabia Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 80 Saudi Arabia Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 81 Saudi Arabia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 82 Saudi Arabia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 83 Saudi Arabia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 84 Saudi Arabia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 85 Saudi Arabia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 86 Saudi Arabia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 87 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 88 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 89 South Africa Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 90 South Africa Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 91 South Africa Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 92 South Africa Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 93 South Africa Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 94 South Africa Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 95 South Africa Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 96 South Africa Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 97 South Africa Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 98 South Africa Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 99 Nigeria Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 100 Nigeria Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 101 Nigeria Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 102 Nigeria Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 103 Nigeria Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 104 Nigeria Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 105 Nigeria Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 106 Nigeria Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 107 Nigeria Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 108 Nigeria Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 109 Rest of LAMEA Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 110 Rest of LAMEA Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 111 Rest of LAMEA Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 112 Rest of LAMEA Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 113 Rest of LAMEA Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 114 Rest of LAMEA Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 115 Rest of LAMEA Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 116 Rest of LAMEA Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 117 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 118 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 119 Key Information – Abbott Laboratories
TABLE 120 Key Information – Siemens Healthineers AG
TABLE 121 Key information – Becton, Dickinson and Company
TABLE 122 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 123 Key Information – Thermo Fisher Scientific, Inc.
TABLE 124 Key Information – Bio-Rad Laboratories, Inc.
TABLE 125 Key Information – Danaher Corporation
TABLE 126 Key Information – DiaSorin S.p.A.
TABLE 127 key Information – PerkinElmer, Inc.
TABLE 128 Key information – BioMérieux S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Abbott Laboratories
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Siemens Healthineers AG
FIG 7 Swot analysis: Siemens AG
FIG 8 Recent strategies and developments: Thermo Fisher Scientific, Inc.